Stem Holdings, Inc. (STMH) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerStem Holdings, Inc. (STMH) trades at $0.00001. Stem Holdings, Inc. is a vertically-integrated cannabis company involved in the production, distribution, and sale of cannabis and cannabis-infused products. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for STMH: STMH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Stem Holdings, Inc. (STMH) Healthcare & Pipeline Overview
Stem Holdings, Inc. is a vertically-integrated cannabis company focused on production, distribution, and technology within the cannabis sector. With a portfolio of cannabis and CBD brands, Stem Holdings operates in a competitive market, navigating regulations and aiming to expand its market share through strategic licensing and e-commerce platforms.
What Is the Investment Thesis for STMH?
Stem Holdings operates in the rapidly expanding cannabis industry, presenting both opportunities and risks. The company's vertically-integrated structure, encompassing cultivation, processing, distribution, and retail, allows for greater control over the supply chain and potentially higher margins. However, the company's market capitalization is $0.00B, and the P/E ratio is -0.00, indicating it's not currently profitable. A key growth catalyst is the potential expansion into new states and the acquisition of additional licenses. Investors should monitor the company's ability to achieve profitability, manage regulatory compliance, and effectively compete with larger players in the cannabis market. The company's success depends on navigating the evolving regulatory landscape and capitalizing on the increasing acceptance of cannabis.
Based on FMP financials and quantitative analysis
STMH Key Highlights
Vertically-integrated operations provide control over the entire cannabis value chain, from cultivation to retail.
- Portfolio of cannabis and CBD brands caters to diverse consumer preferences.
- Ownership interests in 29 state-issued cannabis licenses as of September 30, 2021, enabling multi-state operations.
- Operates Budee and Ganjarunner e-commerce platforms for delivery-as-a-service.
- Market Cap of $0.00B reflects its current valuation in the market.
Who Are STMH's Competitors?
STMH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| NGMC Next Generation Management Corp. | $1.03 | 0.00% | — | |
| AKAN Akanda Corp. | $1.98 | -10.41% | — | |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are STMH's Key Strengths?
Vertically-integrated operations.
- Diverse brand portfolio.
- Extensive licensing portfolio.
- E-commerce platforms for delivery services.
What Are STMH's Weaknesses?
Negative P/E ratio indicates lack of profitability.
- Small market capitalization.
- Dependence on regulatory approvals.
- Intense competition in the cannabis industry.
What Are the Key Risks for STMH?
Financial-distress signal — its Altman Z-Score of -17.10 sits in the distress zone (elevated bankruptcy risk).
- Changing regulatory landscape could negatively impact operations.
- Increased competition from larger players could erode market share.
- Price volatility in the cannabis market could impact revenue and profitability.
- Potential for federal legalization to disrupt state-level markets.
- Limited financial disclosure due to OTC listing increases investment risk.
What Are STMH's Competitive Advantages?
- Vertically-integrated operations provide cost advantages and control over the supply chain.
- Brand portfolio creates customer loyalty and differentiation.
- Extensive licensing portfolio provides a barrier to entry.
- E-commerce platforms provide a competitive advantage in the delivery market.
What Does STMH Do?
Stem Holdings, Inc., incorporated in 2016 and headquartered in Boca Raton, Florida, operates as a vertically-integrated cannabis products and technology company. The company's business encompasses the entire value chain, from cultivation and processing to wholesale distribution and retail sales of cannabis and cannabis-infused products. Stem Holdings has developed a portfolio of brands catering to different consumer segments, including TJ's Gardens, TravisxJames, and Yerba Buena for flower and extracts, Cannavore for edible confections, and Doseology for mass-market CBD products. The company also operates delivery-as-a-service brands, Budee and Ganjarunner, which are e-commerce platforms designed to facilitate online cannabis sales and delivery. As of September 30, 2021, Stem Holdings held ownership interests in 29 state-issued cannabis licenses, including licenses for cultivation, processing, wholesale distribution, hemp production, dispensary operations, and adult-use medical retailers. This extensive licensing portfolio enables the company to operate across multiple states and expand its market reach. Stem Holdings aims to leverage its vertically-integrated model and brand portfolio to capture a significant share of the growing cannabis market.
What Products and Services Does STMH Offer?
- Cultivates cannabis plants.
- Processes cannabis into various forms, including flower, extracts, and concentrates.
- Manufactures cannabis-infused products, such as edibles and topicals.
- Distributes cannabis products to dispensaries and retailers.
- Operates retail dispensaries.
- Provides delivery services through its Budee and Ganjarunner e-commerce platforms.
How Does STMH Make Money?
- Vertically-integrated operations generate revenue from cultivation, processing, distribution, and retail sales.
- Brand portfolio generates revenue through the sale of cannabis and CBD products.
- E-commerce platforms generate revenue through delivery fees and product sales.
- Licensing agreements generate revenue through royalties and fees.
What Industry Does STMH Operate In?
Stem Holdings operates within the rapidly evolving cannabis industry, which is experiencing significant growth due to increasing legalization and acceptance of cannabis for both medical and recreational use. The market is characterized by intense competition, with numerous companies vying for market share. Key trends include the consolidation of smaller players, the rise of branded products, and the increasing importance of e-commerce and delivery services. Stem Holdings' vertically-integrated model and diverse brand portfolio position it to capitalize on these trends, but it faces challenges from larger, more established companies and the complex regulatory landscape.
Who Are STMH's Key Customers?
- Adult-use cannabis consumers.
- Medical cannabis patients.
- Retail dispensaries.
- Wholesale distributors.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Stem Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Boca Raton, US. The company is led by CEO Matthew J. Cohen. STMH has traded publicly since 2021.
Financial Health
Stem Holdings, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -17.10 places it in the distress zone, a signal of elevated financial risk.
Forward Outlook
Wall Street analysts project Stem Holdings, Inc. revenue of about $39.6M for fiscal 2026, with EPS near $-11.00.
Insider Activity
12 transactions · 0 purchases, 0 sales, 12 other transactions · 5 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
STMH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
STMH Latest News
No recent news available for STMH.
STMH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for STMH.
Price Targets
Wall Street price target analysis for STMH.
STMH MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for STMH; grades run from A+ (80-100) to F (below 30).
Leadership: Matthew J. Cohen
CEO
Matthew J. Cohen serves as the CEO of Stem Holdings, Inc. His background includes experience in managing teams and overseeing the operations of the company. As CEO, he is responsible for the overall strategic direction and performance of Stem Holdings, including overseeing its vertically-integrated operations and managing its portfolio of cannabis and CBD brands.
Track Record: Under Matthew J. Cohen's leadership, Stem Holdings has focused on expanding its operations and building its brand portfolio. Key milestones include the acquisition of additional cannabis licenses and the development of its Budee and Ganjarunner e-commerce platforms. However, the company has yet to achieve profitability, and its market capitalization remains relatively small.
STMH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Stem Holdings may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, and trading activity can be sporadic. Investing in companies on the OTC Other tier carries higher risks due to the lack of regulatory oversight and the potential for fraud or manipulation. These companies often do not file with the SEC.
- OTC Tier: OTC Other
- Limited financial disclosure increases information asymmetry.
- Low liquidity can lead to price volatility and difficulty in trading shares.
- Higher risk of fraud or manipulation due to lack of regulatory oversight.
- Potential for delisting or suspension of trading.
- Limited access to capital and financing options.
- Verify the company's registration and licensing status.
- Review available financial statements and disclosures.
- Assess the company's management team and track record.
- Evaluate the company's business model and competitive landscape.
- Analyze the company's capital structure and debt levels.
- Monitor trading activity and price movements.
- Consult with a qualified financial advisor.
- Ownership interests in state-issued cannabis licenses.
- Operation of e-commerce platforms for delivery services.
- Presence of a management team.
- Existence of a portfolio of cannabis and CBD brands.
Common Questions About STMH (Healthcare)
What do analysts say about STMH stock?
However, given the company's OTC listing and small market capitalization, analyst coverage may be limited. Investors should conduct their own due diligence and carefully consider the risks and opportunities associated with investing in STMH. Key valuation metrics to consider include revenue growth, gross margin, and cash flow.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based on available data as of 2026-03-17.
- OTC market investments carry significant risk.